Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

The role of anti-cyclic citrullinated peptide (CCP) antibodies in early detection of rheumatoid arthritis: an overview of the INOVA Diagnostics, Inc. QUANTA Lite CCP assays.

Gilliam BE, Moore TL.

Expert Opin Med Diagn. 2012 Jul;6(4):359-69. doi: 10.1517/17530059.2012.694423. Epub 2012 Jun 19.

PMID:
23480744
2.

Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.

Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.

J Rheumatol. 2004 Sep;31(9):1829-33.

PMID:
15338508
3.

Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.

Vos I, Van Mol C, Trouw LA, Mahler M, Bakker JA, Van Offel J, De Clerck L, Huizinga TW.

Clin Rheumatol. 2017 Jul;36(7):1487-1492. doi: 10.1007/s10067-017-3684-8. Epub 2017 Jun 3.

4.

Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.

Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Rönnelid J, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2011 Feb 3;13(1):R13. doi: 10.1186/ar3237.

5.

Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis.

Swart A, Burlingame RW, Gürtler I, Mahler M.

Clin Chim Acta. 2012 Dec 24;414:266-72. doi: 10.1016/j.cca.2012.09.015. Epub 2012 Sep 25.

6.

Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis.

Shidara K, Inoue E, Tanaka E, Hoshi D, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H.

Rheumatol Int. 2011 May;31(5):617-22. doi: 10.1007/s00296-009-1336-2. Epub 2010 Jan 5.

PMID:
20049446
8.

A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.

Svärd A, Kastbom A, Söderlin MK, Reckner-Olsson Å, Skogh T.

J Rheumatol. 2011 Jul;38(7):1265-72. doi: 10.3899/jrheum.101086. Epub 2011 Apr 1.

PMID:
21459947
9.

Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.

Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.

J Rheumatol. 2006 Dec;33(12):2390-7. Epub 2006 Aug 15.

PMID:
16924694
10.
11.

Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis.

Lutteri L, Malaise M, Chapelle JP.

Clin Chim Acta. 2007 Nov-Dec;386(1-2):76-81. Epub 2007 Aug 16.

PMID:
17826752
12.

Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.

Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.

J Rheumatol. 2007 Aug;34(8):1658-63. Epub 2007 Jul 1.

PMID:
17611988
13.

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.

Alexiou I, Germenis A, Ziogas A, Theodoridou K, Sakkas LI.

BMC Musculoskelet Disord. 2007 Apr 20;8:37.

14.

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ.

Arthritis Rheum. 2003 Oct;48(10):2741-9.

15.

Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis.

Debaugnies F, Servais G, Badot V, Noubouossie D, Willems D, Corazza F.

Scand J Rheumatol. 2013;42(2):108-14. doi: 10.3109/03009742.2012.723746. Epub 2012 Nov 6.

PMID:
23126558
16.

Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.

Jaskowski TD, Hill HR, Russo KL, Lakos G, Szekanecz Z, Teodorescu M.

J Rheumatol. 2010 Aug 1;37(8):1582-8. doi: 10.3899/jrheum.091236. Epub 2010 Jun 1.

18.

Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies.

Pratesi F, Tommasi C, Anzilotti C, Puxeddu I, Sardano E, Di Colo G, Migliorini P.

Clin Exp Immunol. 2011 Jun;164(3):337-45. doi: 10.1111/j.1365-2249.2011.04378.x. Epub 2011 Mar 17.

19.

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.

Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L, Dahlqvist SR.

Arthritis Res Ther. 2004;6(4):R303-8. Epub 2004 May 11.

20.

The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.

Popescu C, Zofotă S, Bojincă V, Ionescu R.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):179-87.

PMID:
24620631

Supplemental Content

Support Center